The global Cell and Gene Therapy Clinical Trial Market is witnessing remarkable growth, with sales valued at US$ 10.7 billion in 2021. The market is projected to expand at an impressive CAGR of 24.9% from 2022 to 2032, reaching a valuation of US$ 119.3 billion by 2032. Oncology, the highest revenue-generating segment, is forecasted to …